Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely azelastine hydrochloride 500 microgram/1 milliliter conventional release eye solution (clinical drug) |
Is a |
False |
Azelastine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Azelastine hydrochloride 140 microgram/actuation nasal spray |
Is a |
False |
Azelastine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Azelastine hydrochloride [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azelastine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely azelastine hydrochloride 500 microgram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azelastine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Azelastine hydrochloride 140 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azelastine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Azelastine hydrochloride 137 mcg nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azelastine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Azelastine hydrochloride 1% spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azelastine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Azelastine hydrochloride 140 microgram/actuation nasal spray |
Has basis of strength substance (attribute) |
True |
Azelastine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Azelastine hydrochloride 140 microgram/actuation nasal spray |
Has precise active ingredient |
True |
Azelastine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely azelastine hydrochloride 500 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Azelastine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely azelastine hydrochloride 500 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has precise active ingredient |
True |
Azelastine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has precise active ingredient |
True |
Azelastine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has basis of strength substance (attribute) |
True |
Azelastine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |